Y36-16953-16904 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-24
Dose 1 — Pfizer-BioNTech
2021-05-15
Dose 2 — Pfizer-BioNTech
2021-05-16
Registered in v-safe
2021-05-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-17
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-05-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-05-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-05-24
Health check-in — day 7, dose 2
Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-29
Survey response — day 14, dose 2
MedDRA: Dizziness, Epistaxis, Headache — Feeling: Poor · Be unable to do your normal daily activities

Free text: Severe headaches, bloody mucus right nostril, dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-16
Survey response — day 28, dose 2
MedDRA: Arthralgia, Energy increased, Eye pain, Fatigue, Headache, Immediate post-injection reaction, Myalgia, Post-acute COVID-19 syndrome, Pre-existing disease, Tinnitus, Vision blurred — Feeling: Poor · Be unable to do your normal daily activities

Free text: Bad headaches, tinnitus, blurry vision, joint pain, muscle aches,fatigue. Eye pain. I have PASC: Long haul COVID. I feel that immediately after the vaccination I felt a boost of energy and a bit better however now Im relapsing to my prevax self.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-29
Survey response — day 42, dose 2
MedDRA: Disturbance in attention, Fatigue, Headache, Myalgia, Nausea, Tinnitus, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fatigue, headaches, muscle aches, tinnitus, nausea, blurry vision, concentration problems. NOTE: I HAVE PASC

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-11-13
Survey response — 6 months, dose 2
MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school

Free text: I still have PASC - Post Acute Sequele Covid-19 (Long COVID)

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-24	Pfizer-BioNTech
2	2021-05-15	Pfizer-BioNTech

Free text

Release 8 — day 14, dose 2

2021-05-29

Symptoms: Severe headaches, bloody mucus right nostril, dizziness

Release 9 — day 28, dose 2

2021-06-16

Symptoms: Bad headaches, tinnitus, blurry vision, joint pain, muscle aches,fatigue. Eye pain. I have PASC: Long haul COVID. I feel that immediately after the vaccination I felt a boost of energy and a bit better however now Im relapsing to my prevax self.

Release 9 — day 42, dose 2

2021-06-29

Symptoms: Fatigue, headaches, muscle aches, tinnitus, nausea, blurry vision, concentration problems. NOTE: I HAVE PASC

Release 10 — 6 months, dose 2

2021-11-13

Symptoms: I still have PASC - Post Acute Sequele Covid-19 (Long COVID)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	✓	✓	✓
SD	Disturbance in attention	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Energy increased	✓	✓	✓
SD	Epistaxis	✓	✓	✓
SD	Eye pain	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Immediate post-injection reaction	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Post-acute COVID-19 syndrome	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Tinnitus	✓	✓	✓
SD	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release